Eiko Saijou

492 total citations
10 papers, 376 citations indexed

About

Eiko Saijou is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Eiko Saijou has authored 10 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Eiko Saijou's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Phagocytosis and Immune Regulation (2 papers). Eiko Saijou is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Phagocytosis and Immune Regulation (2 papers). Eiko Saijou collaborates with scholars based in Japan and United States. Eiko Saijou's co-authors include Atsushi Miyajima, Michitaka Matsuda, Keisuke Sekine, Takahiro Naiki, Yuichiro Miyaoka, Minoru Tanaka, Naoko Miyata, Hitoshi Okochi, Shinya Tsurusaki and Minoru Tanaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Eiko Saijou

10 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiko Saijou Japan 7 172 85 83 83 80 10 376
Xuzhen Yan China 10 129 0.8× 51 0.6× 125 1.5× 39 0.5× 121 1.5× 18 337
Kylie P. Matchett United Kingdom 8 177 1.0× 100 1.2× 162 2.0× 55 0.7× 155 1.9× 9 432
Iris Kufferath Austria 8 265 1.5× 37 0.4× 53 0.6× 66 0.8× 31 0.4× 11 396
Judit López‐Luque Spain 8 179 1.0× 80 0.9× 37 0.4× 44 0.5× 73 0.9× 8 368
Adi Egozi Israel 7 245 1.4× 112 1.3× 84 1.0× 30 0.4× 80 1.0× 13 475
Anal Desai United States 5 268 1.6× 46 0.5× 58 0.7× 40 0.5× 37 0.5× 5 412
Ping‐Fang Hu China 13 217 1.3× 49 0.6× 93 1.1× 30 0.4× 94 1.2× 20 410
Yeben Qian China 12 158 0.9× 42 0.5× 50 0.6× 58 0.7× 65 0.8× 24 334
Kazuharu Kukita Japan 9 167 1.0× 107 1.3× 74 0.9× 123 1.5× 20 0.3× 16 368
Yih-Shyong Lai Taiwan 14 205 1.2× 24 0.3× 45 0.5× 148 1.8× 46 0.6× 32 408

Countries citing papers authored by Eiko Saijou

Since Specialization
Citations

This map shows the geographic impact of Eiko Saijou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiko Saijou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiko Saijou more than expected).

Fields of papers citing papers by Eiko Saijou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiko Saijou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiko Saijou. The network helps show where Eiko Saijou may publish in the future.

Co-authorship network of co-authors of Eiko Saijou

This figure shows the co-authorship network connecting the top 25 collaborators of Eiko Saijou. A scholar is included among the top collaborators of Eiko Saijou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiko Saijou. Eiko Saijou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nakano, Yasuhiro, Eiko Saijou, Tohru Itoh, et al.. (2024). Development of a high throughput system to screen compounds that revert the activated hepatic stellate cells to a quiescent-like state. Scientific Reports. 14(1). 8536–8536. 3 indexed citations
2.
Saijou, Eiko, et al.. (2024). Modulation of liver cholesterol homeostasis by choline supplementation during fibrosis resolution. Heliyon. 10(17). e36727–e36727. 2 indexed citations
3.
Koui, Yuta, Yusuke Mori, Yasuhiro Nakano, et al.. (2021). Development of human iPSC-derived quiescent hepatic stellate cell-like cells for drug discovery and in vitro disease modeling. Stem Cell Reports. 16(12). 3050–3063. 23 indexed citations
4.
Saijou, Eiko, Yutaka Enomoto, Michitaka Matsuda, et al.. (2018). Neutrophils alleviate fibrosis in the CCl4‐induced mouse chronic liver injury model. Hepatology Communications. 2(6). 703–717. 65 indexed citations
5.
Matsuda, Michitaka, Shinya Tsurusaki, Naoko Miyata, et al.. (2017). Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice. Hepatology. 67(1). 296–312. 82 indexed citations
6.
Yagai, Tomoki, Satoshi Matsui, Kenichi Harada, et al.. (2017). Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree. PLoS ONE. 12(4). e0175355–e0175355. 4 indexed citations
7.
Saijou, Eiko, Fumitaka Takeshita, Satoshi Nishimura, et al.. (2012). Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis. Proceedings of the National Academy of Sciences. 109(11). 4263–4268. 78 indexed citations
8.
Saijou, Eiko, Tohru Itoh, Kyung‐Woon Kim, et al.. (2007). Nucleocytoplasmic Shuttling of the Zinc Finger Protein EZI Is Mediated by Importin-7-dependent Nuclear Import and CRM1-independent Export Mechanisms. Journal of Biological Chemistry. 282(44). 32327–32337. 21 indexed citations
9.
Naiki, Takahiro, Eiko Saijou, Yuichiro Miyaoka, Keisuke Sekine, & Atsushi Miyajima. (2007). TRB2, a Mouse Tribbles Ortholog, Suppresses Adipocyte Differentiation by Inhibiting AKT and C/EBPβ. Journal of Biological Chemistry. 282(33). 24075–24082. 73 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026